Delivery Order SPE2DB24D2205-SPE2DB25FEFLE
- Not listed
- This is a $1,142.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,567,926,802 units of the vaginal insert medication YUVAFEM 10 MCG. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Yuvafem 10 MCG vaginal inserts, a medical product, with a ceiling value of $1,991.35 and a period of performance through December 4, 2024. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,638.66 firm fixed-price contract is for the delivery of YUVAFEM 10 MCG vaginal inserts. The order has a completion date of May 29, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor for this order, which is issued under the company's $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,562,842 units of YUVAFEM 10 MCG vaginal inserts. The $1,803.24 firm fixed-price contract has a completion date of November 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This is a $1,248.67 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 18 units of the YUVAFEM 10 MCG VAGINAL INSERT product. The contract has a completion date of May 23, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of YUVAFEM 10 MCG vaginal inserts. The $1,344.37 award has a completion date of February 14, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency,...
- The Defense Logistics Agency awarded a $4,965.51 firm fixed price delivery order to Amerisourcebergen Drug Corp for 10 mcg vaginal inserts. As the prime contractor, Amerisourcebergen Drug Corp will deliver YUVAFEM 10 MCG VAGINAL INSERT 18S to the DLA under the terms of this short-term contract running from July 7-10, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform the contract from its location in Conshohocken, Pennsylvania without...
- This federal contract award is for the delivery of Yuvafem 10 MCG vaginal inserts to the Defense Logistics Agency (DLA). The $6,164.41 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 3, 2022. The contract has a completion date of March 4, 2022 and was not set aside for any specific business type. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,624.75 contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, with a completion date of July 9, 2025. This contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,462.37 order is for the supply of YUVAFEM 10 MCG vaginal inserts. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFLEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA contract vehicle. The company's federal contract portfolio demonstrates extensive capabilities in delivering both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, with individual delivery orders ranging significantly in value. This particular order for Yuvafem, a vaginal estrogen replacement therapy product, exemplifies the company's role in supplying specialized pharmaceutical products to support military and veteran healthcare needs through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |